Search

Emeis SA

Open

13.62 -1.94

Overview

Share price change

24h

Current

Min

13.52

Max

13.91

Key metrics

By Trading Economics

Recommendations

By TipRanks

Recommendations

Sell

12 Months Forecast

-26.95% downside

Emeis SA Chart

Past performance is not a reliable indicator of future results.

Related News

6 Jan 2026, 21:14 UTC

Major Market Movers

Ventyx Biosciences Gains on Report of Possible $1 Billion Eli Lilly Deal

6 Jan 2026, 19:23 UTC

Acquisitions, Mergers, Takeovers

OneStream to Go Private Through $6.4 Billion Hg Acquisition

6 Jan 2026, 17:41 UTC

Major Market Movers

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

6 Jan 2026, 15:46 UTC

Acquisitions, Mergers, Takeovers

Advent International Leads InPost Takeover Offer, Sky News Says

6 Jan 2026, 15:37 UTC

Major Market Movers

Terrestrial Energy Shares Rise After DOE Agreement For Nuclear Plant Development

6 Jan 2026, 23:46 UTC

Market Talk

Nikkei May Decline After Hitting Record High -- Market Talk

6 Jan 2026, 23:35 UTC

Market Talk

Gold Edges Higher Amid Ongoing Geopolitical Tensions -- Market Talk

6 Jan 2026, 23:19 UTC

Market Talk

Greatland 2Q Gold Output Strong, Sales Soft -- Market Talk

6 Jan 2026, 22:53 UTC

Market Talk

WiseTech, REA and CAR Look Best Insulated From AI Threat -- Market Talk

6 Jan 2026, 22:03 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 Jan 2026, 22:03 UTC

Acquisitions, Mergers, Takeovers

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 Jan 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 Jan 2026, 21:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6 Jan 2026, 21:12 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

6 Jan 2026, 21:12 UTC

Market Talk

Commodity Demand Helps Canada Reduce Reliance on Trade With U.S. -- Market Talk

6 Jan 2026, 20:59 UTC

Major Market Movers
Acquisitions, Mergers, Takeovers

Ventyx Biosciences Gains on Report of Possible $1B Eli Lilly Deal

6 Jan 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Acquisition of Ventyx Would Bring Lilly Into Emerging Category of Pills for Inflammation-Related Conditions -- WSJ

6 Jan 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly Nears Deal for Biotech Ventyx -- WSJ

6 Jan 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Deal Could Be Announced Imminently, Sources Say -- WSJ

6 Jan 2026, 20:40 UTC

Acquisitions, Mergers, Takeovers

Eli Lilly in Advanced Talks to Buy Ventyx Biosciences For Over $1B, Sources Say -- WSJ

6 Jan 2026, 20:01 UTC

Market Talk

Oil Futures Give Back Post-Venezuela Incursion Gains -- Market Talk

6 Jan 2026, 19:52 UTC

Market Talk

U.S. Natural Gas Falls Awaiting Colder Weather -- Market Talk

6 Jan 2026, 19:46 UTC

Acquisitions, Mergers, Takeovers

Under Armour Stock Rises After the 'Warren Buffet of Canada' Boosts Its Stake -- Barrons.com

6 Jan 2026, 19:08 UTC

Acquisitions, Mergers, Takeovers

OneStream to Go Private Through $6.4B Hg Acquisition

6 Jan 2026, 18:28 UTC

Acquisitions, Mergers, Takeovers

These Stocks Are Moving the Most Today: Sandisk, Nvidia, AMD, Palantir, OneStream, SoFi, Microchip, and More -- Barrons.com

6 Jan 2026, 17:20 UTC

Market Talk
Earnings

Financial Services Roundup: Market Talk

6 Jan 2026, 17:20 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Health Care Roundup: Market Talk

6 Jan 2026, 15:57 UTC

Market Talk

Crude Futures Ease Back From Early Gains -- Market Talk

6 Jan 2026, 15:34 UTC

Market Talk
Earnings

Bank of Montreal Expects to Exit 2027 With ROE Hitting 15% Target -- Market Talk

6 Jan 2026, 15:27 UTC

Market Talk

German Inflation Won't Fall Much Further in 2026 -- Market Talk

Emeis SA Forecast

Price Target

By TipRanks

-26.95% downside

12 Months Forecast

Average 10 EUR  -26.95%

High 10 EUR

Low 10 EUR

Based on 1 Wall Street analysts offering 12 month price targets forEmeis SA - Dist in the last 3 months.

Rating Consensus

By TipRanks

Sell

1 ratings

0

Buy

0

Hold

1

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Emeis SA

emeis Société anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. It operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. The company was founded in 1989 and is headquartered in Puteaux, France.
help-icon Live chat